ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

New Source of Research Funds? As Clinton Derails Tobacco Deal, Prospects May Brighten for Tougher Measures In ‘98

September 19, 1997

Cancer Control Budget Still $4 Million Short

January 28, 1977

Final Money Bill Clear On Permitting New Construction Funding

December 12, 1975

BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery

June 30, 2006

In Brief: Women’s Health Group Asks Magazines To Stop Accepting Tobacco Advertising

June 5, 1998

In Congress: Continuing Resolutions Keep Feds Running; Henney Nomination Stalled By Nickles

October 16, 1998